New Delhi, April 3 -- India's medical device industry is bracing for a major disruption as the US imposes a steep 26% reciprocal tariff on Indian exports.

Industry leaders warn that the move could hinder growth, shake up global supply chains, and create new barriers for Indian manufacturers seeking to expand in the US market.

Read this | Trump's tariff strike: India hit with 26% duty as trade war escalates

In FY24, India's medical device exports to the US stood at $714.38 million, while US exports to India were significantly higher at $1.52 billion, according to the Exports Promotion Council of Medical Devices.

The tariff could disproportionately affect Indian exports of disposables like catheters, syringes, cannulas, and extension li...